Validation and Application of a Multiplex Real-Time PCR Method for Distinguishing Zika Virus, Yellow Fever Virus, Dengue Virus, and Chikungunya Virus (ZYDC-PCR) - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Validation and Application of a Multiplex Real-Time PCR Method for Distinguishing Zika Virus, Yellow Fever Virus, Dengue Virus, and Chikungunya Virus (ZYDC-PCR)

  • By

  • Anne Hauner

  • Ana Julia Benítez

  • Noella Mulopo-Mukanya

  • Stijn Rogé

  • Silvia Serrano

  • Veerle Vanlerberghe

  • Luciana Lepore

  • Marjan Van Esbroeck

  • Justin Masumu

  • Carolyne Nasimiyu

  • M. Kariuki Njenga

  • Maria Eugenia Toledo Romani

  • Yenisbel V. Portal

  • Mayling Álvarez

  • Rosa Ramírez-Bartutis

  • María G. Guzmán

  • Steve Ahuka-Mundeke

  • Daniel Mukadi-Bamuleka

  • Kevin K. Ariën

  • February 6, 2026

Share

Clinical Scorecard: Validation and Application of a Multiplex Real-Time PCR Method for Distinguishing Zika Virus, Yellow Fever Virus, Dengue Virus, and Chikungunya Virus (ZYDC-PCR)

At a Glance

CategoryDetail
ConditionArboviral infections (Zika, Yellow Fever, Dengue, Chikungunya)
Key MechanismsMultiplex real-time PCR for simultaneous detection of four arboviruses
Target PopulationIndividuals at risk of arboviral infections, particularly in tropical and subtropical regions
Care SettingLaboratories for diagnostic testing

Key Highlights

  • Multiplex PCR assay developed for ZIKV, CHIKV, DENV, and YFV
  • Improves differential diagnosis of arboviral infections
  • Addresses high rates of misdiagnosis due to overlapping symptoms
  • Essential for timely multi-pathogen surveillance
  • Laboratory validation conducted in DRC and Cuba

Guideline-Based Recommendations

Diagnosis

  • Utilize multiplex PCR for accurate detection of co-circulating arboviruses
  • Avoid reliance on serological tests due to cross-reactivity

Management

  • Implement timely treatment based on accurate diagnosis
  • Avoid unnecessary antibiotic prescriptions to prevent resistance

Monitoring & Follow-up

  • Conduct regular surveillance of circulating arboviruses
  • Utilize PCR for early detection and outbreak management

Risks

  • Severe complications from misdiagnosed infections
  • Potential for increased mortality without appropriate treatment

Patient & Prescribing Data

Individuals presenting with fever and nonspecific symptoms in endemic areas

Early and accurate diagnosis can significantly reduce case fatality rates

Clinical Best Practices

  • Prioritize laboratory confirmation for arboviral infections
  • Educate healthcare providers on the importance of differential diagnosis
  • Implement vector control measures based on surveillance data

Related Resources & Content

Original Source(s)

Validation and Application of a Multiplex Real-Time PCR Method for Distinguishing Zika Virus, Yellow Fever Virus, Dengue Virus, and Chikungunya Virus (ZYDC-PCR)

  • by Anne Hauner, Ana Julia Benítez, Noella Mulopo-Mukanya, Stijn Rogé, Silvia Serrano, Veerle Vanlerberghe, Luciana Lepore, Marjan Van Esbroeck, Justin Masumu, Carolyne Nasimiyu, M. Kariuki Njenga, Maria Eugenia Toledo Romani, Yenisbel V. Portal, Mayling Álvarez, Rosa Ramírez-Bartutis, María G. Guzmán, Steve Ahuka-Mundeke, Daniel Mukadi-Bamuleka, Kevin K. Ariën

  • February 6, 2026

Related Content

Computational Analysis of NS1 Antigenic Features in Dengue and Zika Viruses for Enhanced Diagnostic Precision

Cytokine Dynamics During Acute Infections of Dengue, Zika, Chikungunya, and Mayaro Viruses in Northern Peru

Immunity to Non-Dengue Flaviviruses Impacts Dengue Virus Immunoglobulin G Enzyme-Linked Immunosorbent Assay Specificity in Cambodia